BR0210317A - Complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções medianas por microorganismos patogênicos intracelulares nos mamìferos - Google Patents
Complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções medianas por microorganismos patogênicos intracelulares nos mamìferosInfo
- Publication number
- BR0210317A BR0210317A BR0210317-6A BR0210317A BR0210317A BR 0210317 A BR0210317 A BR 0210317A BR 0210317 A BR0210317 A BR 0210317A BR 0210317 A BR0210317 A BR 0210317A
- Authority
- BR
- Brazil
- Prior art keywords
- leishmaniasis
- mammals
- prevention
- treatment
- therapeutic vaccine
- Prior art date
Links
- 208000004554 Leishmaniasis Diseases 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 230000003834 intracellular effect Effects 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- 229940021747 therapeutic vaccine Drugs 0.000 title abstract 3
- 244000000010 microbial pathogen Species 0.000 title abstract 2
- 230000001404 mediated effect Effects 0.000 abstract 2
- 241000282465 Canis Species 0.000 abstract 1
- 241000283086 Equidae Species 0.000 abstract 1
- 241000282324 Felis Species 0.000 abstract 1
- 241000282412 Homo Species 0.000 abstract 1
- 241001137872 Leishmania sp. Species 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 230000029142 excretion Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"COMPLEXO DE VACINA TERAPêUTICA DESTINADO à PREVENçãO OU AO TRATAMENTO DE LEISHMANIOSES E INFECçõES MEDIADAS POR MICROORGANISMOS PATOGêNICOS INTRACELULARES NOS MAMìFEROS". Complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções mediadas por microorganismos patogênicos intracelulares nos mamíferos e em particular no homem, nos caninos, nos felinos e nos eq³ídeos, caracterizado pelo fato de que ele é composto por moléculas de excreção secreção provenientes de promastigotos de Leishmania sp. produzidos em um meio sem germes e sem soro definido.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0107606A FR2825633B1 (fr) | 2001-06-11 | 2001-06-11 | Complexe vaccinal therapeutique destine a la prevention et au traitement des leishmanioses et des infections a microorganismes pathogenes intracellulaires chez le mammifere |
| PCT/FR2002/001823 WO2002100430A1 (fr) | 2001-06-11 | 2002-05-30 | Complexe vaccinal destine a la prevention et au traitement des leishmanioses |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| BR0210317A true BR0210317A (pt) | 2004-08-10 |
| BRPI0210317B1 BRPI0210317B1 (pt) | 2018-09-11 |
| BRPI0210317B8 BRPI0210317B8 (pt) | 2018-10-09 |
| BRPI0210317C1 BRPI0210317C1 (pt) | 2021-05-25 |
Family
ID=8864170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0210317A BRPI0210317C1 (pt) | 2001-06-11 | 2002-05-30 | complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções mediadas por microorganismos patogênicos intracelulares nos mamíferos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060073170A1 (pt) |
| EP (1) | EP1395282B1 (pt) |
| AT (1) | ATE321568T1 (pt) |
| BR (1) | BRPI0210317C1 (pt) |
| CY (1) | CY1105309T1 (pt) |
| DE (1) | DE60210276T2 (pt) |
| ES (1) | ES2260440T3 (pt) |
| FR (1) | FR2825633B1 (pt) |
| PT (1) | PT1395282E (pt) |
| WO (1) | WO2002100430A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8968749B2 (en) * | 2006-07-21 | 2015-03-03 | Universidade Federal De Minas Gerais—Ufmg | Vaccine composition and immunization method |
| US9650639B2 (en) | 2008-05-19 | 2017-05-16 | Advaxis, Inc. | Dual delivery system for heterologous antigens |
| US9017660B2 (en) | 2009-11-11 | 2015-04-28 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors |
| JP5757863B2 (ja) | 2008-05-19 | 2015-08-05 | アドバクシス インコーポレイテッド | 異種抗原のための二重送達システム |
| US10016617B2 (en) | 2009-11-11 | 2018-07-10 | The Trustees Of The University Of Pennsylvania | Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers |
| ES2595207T3 (es) * | 2010-05-07 | 2016-12-28 | Virbac | Composición de vacuna para prevenir o tratar la leishmaniosis |
| CN107412756A (zh) | 2010-10-01 | 2017-12-01 | 宾夕法尼亚大学理事会 | 李斯特菌疫苗载体用于在寄生虫感染的个体中扭转免疫无应答的用途 |
| CA2829960A1 (en) | 2011-03-11 | 2012-09-20 | John Rothman | Listeria-based adjuvants |
| BR112014022662A2 (pt) | 2012-03-12 | 2017-10-03 | Advaxis Inc | Inibição da função de célula supressora seguindo tratamento de vacina de listeria |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4206252A (en) * | 1977-04-04 | 1980-06-03 | Gordon Roy G | Deposition method for coating glass and the like |
| US5599387A (en) * | 1993-02-16 | 1997-02-04 | Ppg Industries, Inc. | Compounds and compositions for coating glass with silicon oxide |
| FR2705358B1 (fr) * | 1993-05-13 | 1995-08-04 | Orstom | Procédé de culture in vitro de différents stades de parasites tissulaires, stades parasitaires obtenus et applications biologiques. |
| WO2000015572A2 (en) * | 1998-09-17 | 2000-03-23 | Libbey-Owens-Ford Co. | Heat strengthened coated glass article and method for making same |
| US6342925B1 (en) * | 1999-01-15 | 2002-01-29 | Sharp Laboratories Of America, Inc. | Automatic audio and video parameter adjustment |
| US7738550B2 (en) * | 2000-03-13 | 2010-06-15 | Sony Corporation | Method and apparatus for generating compact transcoding hints metadata |
| BRPI0114262B1 (pt) * | 2000-09-27 | 2018-09-25 | Thomson Licensing Sa | sistema para otimização automática dos modos de saída de áudio e vídeo para saída de um dispositivo multimídia |
| US6967588B2 (en) * | 2002-03-25 | 2005-11-22 | Sony Corporation | System and method for controlling a home entertainment system |
-
2001
- 2001-06-11 FR FR0107606A patent/FR2825633B1/fr not_active Expired - Fee Related
-
2002
- 2002-05-30 BR BRPI0210317A patent/BRPI0210317C1/pt not_active IP Right Cessation
- 2002-05-30 EP EP02738290A patent/EP1395282B1/fr not_active Expired - Lifetime
- 2002-05-30 WO PCT/FR2002/001823 patent/WO2002100430A1/fr not_active Ceased
- 2002-05-30 ES ES02738290T patent/ES2260440T3/es not_active Expired - Lifetime
- 2002-05-30 DE DE60210276T patent/DE60210276T2/de not_active Expired - Fee Related
- 2002-05-30 AT AT02738290T patent/ATE321568T1/de not_active IP Right Cessation
- 2002-05-30 PT PT02738290T patent/PT1395282E/pt unknown
- 2002-05-30 US US10/480,026 patent/US20060073170A1/en not_active Abandoned
-
2006
- 2006-06-19 CY CY20061100820T patent/CY1105309T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20060073170A1 (en) | 2006-04-06 |
| CY1105309T1 (el) | 2010-03-03 |
| WO2002100430B1 (fr) | 2003-02-13 |
| EP1395282A1 (fr) | 2004-03-10 |
| FR2825633B1 (fr) | 2005-12-16 |
| DE60210276T2 (de) | 2006-11-30 |
| BRPI0210317B1 (pt) | 2018-09-11 |
| BRPI0210317C1 (pt) | 2021-05-25 |
| DE60210276D1 (de) | 2006-05-18 |
| BRPI0210317B8 (pt) | 2018-10-09 |
| WO2002100430A1 (fr) | 2002-12-19 |
| EP1395282B1 (fr) | 2006-03-29 |
| PT1395282E (pt) | 2006-07-31 |
| ES2260440T3 (es) | 2006-11-01 |
| ATE321568T1 (de) | 2006-04-15 |
| FR2825633A1 (fr) | 2002-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9909668A (pt) | Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções | |
| EA200400481A1 (ru) | Применение флибансерина для лечения половых расстройств | |
| MA26992A1 (fr) | Derives de phenethanolamine pour le traitement des maladies respiratoires | |
| DZ1877A1 (fr) | Forme posologiques d'azithromycine pour le traitement d'infection microbiennes. | |
| BRPI0414435A (pt) | métodos e reagentes para o tratamento de distúrbios imunoinflamatórios | |
| DE60218493D1 (de) | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten | |
| PT1326635E (pt) | Composicao farmaceutica para imunizacao contra a sida | |
| BR9609413A (pt) | Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais | |
| MA27929A1 (fr) | Utilisation de calcitonine pour le traitement de l'osteoarthrite | |
| BR0111892A (pt) | Bis-arilsulfonas | |
| BRPI0210317B8 (pt) | complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções mediadas por microorganismos patogênicos intracelulares nos mamíferos | |
| BR0211830A (pt) | Dose única de azitromicina | |
| ATE258057T1 (de) | Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen | |
| MY139368A (en) | Novel cyclohexyl sulphones | |
| MXPA02012857A (es) | Uso de una formulacion elaborada de o que contiene al menos un suero de leche dismilado. | |
| FR2800614B1 (fr) | Composition pour le traitement des infections des voies respiratoires | |
| BR0210632A (pt) | Tratamento de doença parasìtica | |
| ES2093257T3 (es) | Utilizacion de torasemida para la preparacion de medicamentos destinados al tratamiento de edemas cerebrales. | |
| MA25852A1 (fr) | Methode pour le traitement de l'inflammation. | |
| ATE308895T1 (de) | Behandlung von infektionen in tieren | |
| BR0007491A (pt) | Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções | |
| BR0309684A (pt) | O tratamento de dor com ifendropil | |
| AUPR412901A0 (en) | Agents for the prevention and treatment of sexually transmitted disease s - II | |
| BR0210875A (pt) | Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentes | |
| BR0211533A (pt) | Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/09/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/09/2018, OBSERVADAS AS CONDICOES LEGAIS. (CO) REFERENTE A RPI 2488 DE 11/09/2018, QUANTO AO NOME DO TITULAR. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/05/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 21A ANUIDADE. |
|
| B21H | Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2725 DE 28/03/2023 POR TER SIDO INDEVIDA, UMA VEZ QUE O PRAZO DE VALIDADE DA PATENTE TERMINOU EM 30/05/2022. |
|
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 30/05/2022 |